Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Jaechul LimDepartment of Immunobiology, Yale School of Medicine, Yale University, New Haven, CT, USA.
Mi-Ae JangDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.ORCID http://orcid.org/0000-0002-6558-5236
Emily N ForrestDepartment of Genetics, Yale School of Medicine, Yale University, New Haven, CT, USA.
Yuna KimDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, USA.
Meaghan DonahueDepartment of Genetics, Yale School of Medicine, Yale University, New Haven, CT, USA.
Sungsin JoDepartment of Biology, Soonchunhyang University, Asan, South Korea.
Sheng-Nan QiaoDepartment of Genetics, Yale School of Medicine, Yale University, New Haven, CT, USA.
Dong Eun LeeDepartment of Systems Biology, Yonsei University, Seoul, South Korea.
Jun Young HongDepartment of Systems Biology, Yonsei University, Seoul, South Korea.
Yan XiongMount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-3862-3663
Jian JinMount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-2387-3862
Molecular and circuitry mechanism underlying autism behaviors in Shank3 mouse modelsR01MH117289 · NIMH · YALE UNIVERSITY · PI JIANG, YONG-HUI · 2019 to 2023
$3.2M
Genome Architecture in Human Germinal Center B Cell Development, Malignancy, and Somatic HypermutationU01CA260701 · NCI · YALE UNIVERSITY · PI SCHATZ, DAVID G., WANG, SIYUAN · 2020 to 2024
$3.1M
Characterizing the (epi)genetics of oxytocin response in clinical and animal modelsR01HD088007 · NICHD · DUKE UNIVERSITY · PI GREGORY, SIMON G, JIANG, YONG-HUI · 2017 to 2021
$2.9M
Epigenetic Therapy and Prader-Willi SyndromeR01HD088626 · NICHD · YALE UNIVERSITY · PI JIANG, YONG-HUI, JIN, JIAN · 2017 to 2021
$2.8M
Novel Inhibitors of Lysine Methyltransferases G9a and GLP for the Treatment of Alzheimer's DiseaseR01AG084184 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jian Jin · 2023 to 2026
$2.6M
Building the 3D genomic regulatomeDP2GM137414 · NIGMS · YALE UNIVERSITY · PI WANG, SIYUAN · 2019 to 2019
$2.5M
Integrative single-cell spatial genomic, transcriptomic, and epigenetic imaging in mammalian tissueR01HG011245 · NHGRI · YALE UNIVERSITY · PI WANG, SIYUAN · 2020 to 2023
$2.1M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
Therapeutic potential for Prader-Willi syndromeR21HD077197 · NICHD · DUKE UNIVERSITY · PI JIANG, YONG-HUI · 2014 to 2015
$413k
National Research Foundation of Korea (NRF) 2021R1A6A1A03039503National Research Foundation of Korea (NRF) 2021R1C1C1005725National Research Foundation of Korea (NRF) RS-2024-00335057National Research Foundation of Korea (NRF) RS-2024-00409006National Research Foundation of Korea (NRF) Yonsei Education and Research Center for Biosystems, Brain Korea 21 Four programNCI NIH HHS U01 CA260701NHGRI NIH HHS R01 HG011245NIA NIH HHS R01 AG084184NICHD NIH HHS R01 HD088007NICHD NIH HHS R01 HD088626NICHD NIH HHS R21 HD077197NIGMS NIH HHS DP2 GM137414NIH HHS S10 OD030363NIMH NIH HHS R01 MH117289U.S. Department of Health & Human Services | National Institutes of Health (NIH) DP2GM137414U.S. Department of Health & Human Services | National Institutes of Health (NIH) HD077197U.S. Department of Health & Human Services | National Institutes of Health (NIH) HD088007U.S. Department of Health & Human Services | National Institutes of Health (NIH) HD088626U.S. Department of Health & Human Services | National Institutes of Health (NIH) MH117289U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AG084184U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HD088626U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HG011245U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01CA260701
6 · The paper itself
Abstract
Prader-Willi Syndrome (PWS) is caused by the loss of expression of paternally expressed genes in the human 15q11.2-q13 imprinting domain. A set of imprinted genes that are active on the paternal but silenced on the maternal chromosome are intricately regulated by a bipartite imprinting center (PWS-IC) located in the PWS imprinting domain. We previously discovered that euchromatic histone lysine N-methyltransferase-2 (EHMT2/G9a) inhibitors are capable of un-silencing PWS-associated genes by restoring their expression from the maternal chromosome. Here, in mice lacking the Ehmt2 gene, we document un-silencing of the imprinted Snrpn/Snhg14 gene on the maternal chromosome in the late embryonic and postnatal brain. Using PWS and Angelman syndrome patient derived cells with either paternal or maternal deletion of 15q11.2-q13, we have found that chromatin of maternal PWS-IC is closed and has compact 3D folding confirmation. We further show that a distinct noncoding RNA (TSS4-280118) preferentially transcribed from the upstream of the PWS-IC of maternal chromosome interacts with EHMT2 and forms a heterochromatin complex in CIS on the maternal chromosome. Inactivation of TSS4-280118 by CRISPR/Cas9 editing results in unsilencing of the expression of SNRPN and SNORD116 from the maternal chromosome. Taken together, these findings demonstrate that allele-specific recruitment of EHMT2 is required to maintain the maternal imprints. Our findings provide mechanistic insights and support a model for imprinting maintenance of the PWS imprinted domain.
Indexed as
Genomic ImprintingHistone-Lysine N-MethyltransferasePrader-Willi SyndromeAngelman SyndromeAnimalsBrainChromatinChromosomes, Human, Pair 15DNA MethylationFemaleHumansMaleMiceMice, KnockoutRNA, Long NoncodingsnRNP Core ProteinsChromatinG9a protein, mouseHistone-Lysine N-MethyltransferaseRNA, Long NoncodingsnRNP Core ProteinsSNRPN protein, human
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome. · full record | OpenQuestion